首页 > 市场调查报告书 > 医疗设备

子宫内避孕器（IUD）市场规模、份额及成长分析（按类型和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1904768

子宫内避孕器（IUD）市场规模、份额及成长分析（按类型和地区划分）－2026-2033年产业预测

Intrauterine Devices Market Size, Share, and Growth Analysis, By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing25-34 years), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，子宫内避孕器 (IUD) 市场规模将达到 33.6 亿美元，到 2025 年将达到 34.9 亿美元，到 2033 年将达到 47 亿美元，预测期（2026-2033 年）的复合年增长率为 3.8%。

子宫内避孕器（IUD）市场正经历显着成长，这主要得益于多种因素，包括意外怀孕和不安全堕胎的增加，以及人们对这些避孕方法的认知度不断提高。政府的扶持政策和主要企业对先进设备研发的投入，都在推动市场需求。尤其是在美国，计划性延迟生育的趋势，使得人们更容易获得生殖健康服务。然而，子宫内避孕器使用认知度低、潜在的副作用（如疼痛和不规则出血）以及过早取出等问题，都对市场扩张构成了阻碍。同时，新兴经济体可支配收入的增加和人们对健康生活方式日益增长的关注，也为市场创造了机会。有利的法规环境和持续的技术创新有望进一步巩固市场格局。

子宫内避孕器市场驱动因素

人们对计划生育的认识不断提高，对可靠避孕方法的需求日益增长，这极大地推动了子宫内避孕器市场的成长。随着越来越多的人和医疗专业人员认识到长期避孕方案的益处，子宫内避孕器的普及率和需求量也随之飙升。这种意识的转变凸显了有效生殖健康选择的重要性，从而促进了子宫内避孕器的广泛接受和使用。因此，在各方共同致力于帮助个人就其生殖健康和计划生育策略做出知情选择的推动下，子宫内避孕器市场正经历强劲成长。

限制子宫内避孕器市场的因素

由于子宫内避孕器市场受到严格的监管架构限制，因此面临许多限制因素。对于製造商而言，确保产品符合安全性和有效性标准是一项复杂的挑战，通常需要大量的文件工作和核准流程。这种监管负担不仅给现有企业带来挑战，也阻碍了新进入者在市场中立足。因此，这些严格的要求可能会抑制市场整体成长，并阻碍潜在竞争对手在子宫内避孕器领域寻求商机。

子宫内避孕器市场趋势

受意外怀孕率上升和生殖健康意识增强的推动，子宫内避孕器（IUD）市场呈现显着成长趋势。尤其是含激素子宫内避孕器，因其既能有效避孕又能缓解月经症状（如经痛和月经月经）的双重益处而备受关注。卫生组织为推广计划生育和提高公众对各种避孕方法益处的认识所做的努力，也进一步促进了市场成长。此外，子宫内避孕器安全性高，能最大程度降低子宫外孕和生殖健康问题的风险，因此在未生育女性和青少年女性中越来越受欢迎，这也反映了这一趋势。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

AbbVie Inc.
Bayer AG
CooperSurgical Inc.
DKT International
EUROGINE, SL
Mona Lisa NV
OCON Medical Ltd.
Pregna International Limited.
Prosan International BV
SMB Corporation of India
Teva Pharmaceuticals
ANI Pharmaceuticals
Mylan NV（Viatris）
Melbea AG
Contrel Europe
Durbin
Gima SpA
HLL Lifecare Limited
Meril Life Sciences Pvt. Ltd
Mona Lisa NV

结论与建议

简介目录

Product Code: SQMIG35A2678

Intrauterine Devices Market size was valued at USD 3.36 Billion in 2024 and is poised to grow from USD 3.49 Billion in 2025 to USD 4.7 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The intrauterine devices (IUD) market is experiencing significant growth due to various driving factors, including the rising incidence of unplanned pregnancies and unsafe abortions, along with heightened awareness of these contraceptive options. Demand is bolstered by government initiatives and key players investing in research to develop advanced devices. The trend of planned delayed pregnancies, especially in the U.S., is facilitating access to reproductive health services. However, challenges such as limited awareness regarding IUD use, potential side effects like pain and irregular bleeding, and premature removal hinder market expansion. In contrast, increasing disposable incomes and a growing focus on healthy lifestyles in emerging economies present opportunities. Favorable regulations and ongoing technological advancements are anticipated to further enhance the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intrauterine Devices Market Segments Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Intrauterine Devices Market

The rising awareness surrounding family planning and the necessity for reliable contraception methods has significantly fueled the growth of the intrauterine devices market. As more individuals and healthcare professionals acknowledge the advantages of long-lasting birth control solutions, the popularity and demand for IUDs have surged. This shift in perception emphasizes the importance of effective reproductive health options, leading to greater acceptance and utilization of intrauterine devices. Consequently, the market is experiencing robust growth, driven by the collective focus on empowering individuals to make informed choices about their reproductive health and family planning strategies.

Restraints in the Intrauterine Devices Market

The market for intrauterine devices faces significant constraints due to the rigorous regulatory frameworks governing these medical products. Ensuring compliance with safety and efficacy standards can prove to be a complex task for manufacturers, often requiring extensive documentation and approval processes. This regulatory burden not only poses challenges for existing players but also serves as a barrier to new entrants seeking to establish themselves in the market. Consequently, these stringent requirements can impede overall market growth, as potential competitors may be deterred from pursuing opportunities in the intrauterine device sector.

Market Trends of the Intrauterine Devices Market

The Intrauterine Devices (IUDs) market is experiencing a notable upward trend driven by the rising incidence of unplanned pregnancies and an increasing awareness of reproductive health. Hormonal IUDs are particularly gaining traction for their dual benefits of effective contraception and management of menstrual symptoms, including severe cramps and heavy bleeding. Initiatives by health organizations to promote family planning and educate the public on the advantages of various contraceptive methods further enhance market growth. This trend is also reflected in the growing acceptance of IUDs among nulliparous women and adolescents, thanks to their safety profile, which minimizes risks associated with ectopic pregnancies and reproductive health issues.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2026-2033)

Nonhormonal: Copper-containing IUD
Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2026-2033)

25-34 years
35-44 years
Above 44 years
15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2026-2033)

Hospital
Gynecology Clinics
Community Health Care Centers
Others

Global Intrauterine Devices Market Size by End User & CAGR (2026-2033)

Hospitals
Clinics
Community Health Care Centres
Others

Global Intrauterine Devices Market Size by Region & CAGR (2026-2033)

North America, (by Type, by Age Group, by Distribution Channel, by End User)
- US
- Canada
Europe, (by Type, by Age Group, by Distribution Channel, by End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DKT International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROGINE, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mona Lisa N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCON Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pregna International Limited.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prosan International BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMB Corporation of India
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ANI Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan NV (Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Melbea AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Contrel Europe
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Durbin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gima S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mona Lisa N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments